Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma
2023 · Neuro-Oncology Advances · 5 citations
https://doi.org/10.1093/noajnl/vdad106
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
24
Citations
3
h-index
1
i10-index
Raman Agnihotram is an academic researcher from McGill University Health Centre. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Brain Metastases and Treatment & Esophageal Cancer Research and Treatment. The author has an h-index of 3, co-authored 9 publications.
https://doi.org/10.1093/noajnl/vdad106
https://doi.org/10.1016/j.clnesp.2024.10.015
Click to start Chat